ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.100
+0.020 (0.65%)
At close: Nov 28, 2025
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €49.95 million as of November 28, 2025. Its market cap has increased by 8.39% in one year.
Market Cap
49.95M
Enterprise Value
51.72M
Revenue
6.23M
Ranking
n/a
PE Ratio
107.81
Stock Price
€3.10
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 49.95M, an increase of 1,891.67%. That is a compound annual growth rate of 12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 49.95M | 26.02% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | 2.96M | -59.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 142.36B |
| Sanofi | 104.35B |
| Sartorius Stedim Biotech | 20.17B |
| bioMérieux | 12.74B |
| Eurofins Scientific SE | 10.39B |
| Ipsen | 10.21B |
| ABIVAX Société Anonyme | 8.16B |
| Virbac | 3.08B |